Operator
[Operator Instructions]
I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer for REGENXBIO. You may begin.
Patrick J. Christmas
Good afternoon and thank you for joining us today.
With us are Ken Mills, REGENXBIO s President and Chief Executive Officer, Dr. Steve Pakola, our Chief Medical Officer, Dr. Olivier Danos our Chief Scientific Officer, and Vit Vasista, our Chief Financial Officer.
Earlier this afternoon, REGENXBIO released financial and operating results for the fourth quarter and full year ended December 31, 2020. The press release reporting our financial results is available on our website at www.regenxbio.com.